Precigen Inc PGEN:NASDAQ

Last Price$1.24NASDAQ Closing Price as of 4:00PM ET 5/20/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.01(0.80%)
Bid (Size)$1.21 (10)
Ask (Size)$1.25 (48)
Day Low / High$1.21 - 1.28
Volume1.1 M

Precigen Gets FDA Nod to Begin Early-Stage PRGN-3007 Trial in Hematological, Solid Tumors

1:54PM ET 10/26/2021 MT Newswires
Precigen (PGEN) said Tuesday that the US Food and Drug Administration has approved its investigational new drug application to initiate the phase 1/1b test of PRGN-3007 in advanced hematological and solid tumors.

The first-in-human study will be conducted in collaboration with the H. Lee Moffitt Cancer Center & Research Institute, it said.

Price: 4.64, Change: +0.07, Percent Change: +1.42